SAN FRANCISCO The caffeine-fueled environs of the Moscone Center here in the City by the Bay once again serve as host to Transcatheter Cardiovascular Therapeutics, sponsored by the Cardiovascular Research Foundation (CRF; New York), but the gorgeous weather in the 94103 zip code ran counter to the dour mood of the Monday morning session on the future of the drug-eluting stent (DES).